Mar 15, 2023
The applications of Artificial Intelligence (AI) In Drug Commercialization is growing at an unprecedented rate. It provides several benefits
Read More...
Mar 13, 2023
Owning to evolution of genomic profiling technologies, cancer biomarkers are becoming increasingly relevant in management of cancer patients.
Read More...
Mar 08, 2023
Burn is one of the most severe and rapidly growing burdens worldwide, leading to a very high number of mortality and morbidity yearly. It can have intense physical, socioeconomic, and psychological consequences on the person and their family. As per the latest assessment by DelveInsight, incident cases of burns req...
Read More...
Mar 06, 2023
With a robust pipeline aiming to address the underserved market, the future of acute ischemic stroke treatment market holds much promise.
Read More...
Mar 01, 2023
Next-Generation Sequencing (NGS) or commonly referred to as deep sequencing or massively parallel sequencing, is an important field of sequencing technology applied to determine the RNA or DNA sequence. It aims to provide detailed information about the genetic variation in organisms, diseases, or other biological p...
Read More...
Feb 27, 2023
Future of MRD testing looks promising, as ultra-sensitive MRD testing methods have already proven useful in numerous clinical studies.
Read More...
Feb 24, 2023
Oncology drugs pipeline is also looking promising, with potential candidates such as Lynparza, Trodelvy, Glofitamab, Epcoritamab, and others.
Read More...
Feb 22, 2023
The Protein Supplements Market is rising owing to growing demand among fitness enthusiasts. Companies are developing protein products to cater different needs
Read More...
Feb 17, 2023
Absence of approved drugs for EBV treatment offers many opportunities for pharma companies to take advantage of an untapped EBV market.
Read More...
Feb 15, 2023
Pacemakers Market is growing at an immense pace. Major development has been registered in the market. Several MedTech Companies are developing Pacemakers
Read More...
The Next Wave of Radioligand Therapies: 5 Candidates to Watch
Mar 20, 2026
Emerging TIL Therapies Poised to Broaden the Landscape Beyond AMTAGVI
Mar 06, 2026
BYSANTI Approval Positions Vanda to Compete in the Antipsychotic Market
Mar 02, 2026
Newsletter/Whitepaper